🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

MIT just emailed postdocs announcing raising the postdoc minimum to $65k starting Jan 2023. It’s ~$10k more than the previous minimum. With cost of living & inflation the extra will help. Thank you for listening to us! And thank you to those who advocated for us!

A full conference featuring Woman in Immunology. Also, my first time as a speaker in this field. Feels like I’m living a dream!! Thanks for having me UCSF Immunologists for Gender Equity

If women ran the country, and they passed laws affecting men’s reproductive organs, I wonder what the men would do?

Excited to announce the publication of my first, first-author research paper! Daniel Bryan Goodman Kole Roybal and I illustrate the power of 'CAR Pooling' for #cancer #immunotherapy. Click below to read more about our signaling libraries and the BAFF-R CAR #ucsf #cancerresearch #synbio

Presenting a new “CAR Pooling” technique, Daniel Bryan Goodman, Kole Roybal, and co. comb through domains from various immune lineages to build new #CARTCell designs and identify several that boost anticancer efficacy against #MultipleMyeloma in mice. Parker Institute for Cancer Immunotherapy scim.ag/uM

Read our work in Science Translational Medicine - beautiful work by Daniel Bryan Goodman and Camillia Azimi !

Our courageous postdoc research scientists deserve a strong first contract that expands housing access and meets their childcare needs. There is no research without the researchers. Proud to stand with Sinai Postdoctoral Organizing Committee-UAW 💪🏽

So excited to finally share the incredible work of @jcole_garcia from Kole Roybal 's lab at UC San Francisco! Such a fantastic project by them and Jaehyuk Choi and Jay Daniels that will truly advance the CAR T space. nature paper out today

Such a great reminder of an exciting time with Cancer Research Institute fellows studying emerging technologies in #bioinformatics! #immunology #immunotherapy

Pleased to share our latest work from Miriam Merad, MD, PhD lab Lipschultz Precision Immunology Institute, where we try to address the Q: Do tumors alter the epigenetic state of myeloid progenitors in marrow, and are certain aspects of immunosuppressive mono-macrophage fate sealed before they enter the tumor?🧵

Simple math that even if you submit 1/cycle for 3 cycles per year, it’s only 12 total over 4 years. How many grants are you all submitting?

Grateful for the continued support of Cancer Research Institute and its inspiring community! Excited to share my journey and enthusiasm in this video: youtu.be/Piihfjuuet0 Lipschultz Precision Immunology Institute

📰PAPER Cell from IGI Director Brian Brown shows how ovarian cancers evolve local neighborhood control and use IL-4 to resist anti-PD-1 immunotherapy. The findings support a key role for type 2 immunity in cancer and the possibility of drugging this pathway for therapy.

First lab tweet! Sharing new papers: PRINT Using Perturb-map, we show how ovarian tumors resist immunotherapy loom.ly/eHXDm4w PREPRINT Developed new technology to easily generate cell-targeted LNP-RNA Sandro Santagata Joshua Brody, MD Yizhou Dong

So incredibly honored to be a part of the 2024 #HHMI #HannaGrayFellows! Very exited to continue this work with my fantastic PIs Miriam Merad, MD, PhD and Brian Brown at Icahn School of Medicine at Mount Sinai and for the many discoveries that lie ahead! #Immunotherapy #Immunology #SyntheticImmunology #Science

🎉 CONGRATULATIONS 🥳 to Camillia Azimi from the Miriam Merad, MD, PhD and Brown Lab labs on her selection to the 2024 HHMI #HannaGrayFellows! Look out for her new chimeric🏎️🏁 designed to reprogram macrophages at disease sites for targeted therapy in 2025: hhmi.org/news/hhmi-name…

Meet the newly named #HannaGrayFellows! 👋 “HHMI is committed to investing in scientists who dare to tackle some of the biggest challenges of our lifetime,” said HHMI Vice President and Chief Scientific Officer Leslie Vosshall. “Our Hanna Gray Fellows are not only exceptional

🎉Join us in celebrating and congratulating CRI-Merck Postdoctoral Fellow Dr. Camillia Azimi of Icahn School of Medicine at Mount Sinai, who has been named a member of the 2024 cohort of Hanna Gray Fellows, by HHMI! #Immunotherapy

Congratulations to Camillia Azimi for this tremendous honor. Camillia, you make Mount Sinai very proud. Icahn School of Medicine at Mount Sinai

JUST IN: A federal judge in Massachusetts has blocked the Trump administration's rate change to NIH grants.